Pharmaceutical CDMO Market: Why Drugmakers Keep Outsourcing Manufacturing
  Pharmaceutical companies once built vast in-house manufacturing empires. Today, many are deliberately shrinking them. Rising development costs, complex biologics, and global regulatory demands have pushed drugmakers toward outsourcing, and contract development and manufacturing organizations (CDMOs) have become strategic partners rather than mere suppliers. The pharmaceutical CDMO and...
0 Comments 0 Shares 47 Views 0 Reviews